Financials
Financial year 2025
Worth noting
- The team shrank two years in a row.
- Figures corrected afterwards (2024).
Revenue
€ 296.7 million
▲ 8% vs 2024
Profit
Healthy€ 15.1 million
▼ 63% vs 2024
Debts
Low€ 128.3 million
▲ 98% vs 2024
SANOFI BELGIUM from Machelen (Brab.), company number BE0464435901, closed financial year 2025 with a result of € 15.1 million after tax. For that financial year SANOFI BELGIUM recorded revenue of € 296.7 million and equity of € 87.2 million. Compared with financial year 2024, the result moved from € 40.4 million to € 15.1 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
What happened at SANOFI BELGIUM?
What happened at SANOFI BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Hao Zheng stepped down as director. NBB
- Bart Vermeulen stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 15.1 million (▼ 63% vs 2024). Source: NBB ↗
- Hao Zheng became a director. NBB
- Bart Vermeulen became a director. NBB
- New establishment in Brussel. KBO
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 2.7 million profit in 2021 to € 15.1 million profit in 2025.
Paid € 10.3 million in corporate taxes since 2021.
Best year ever: 2024, with € 40.4 million profit.
Paid out € 27 million in dividends to the owners in total.
A new publication or filing at SANOFI BELGIUM? We notify you, reason included.
Follow SANOFI BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Sanofi-Aventis Participations (90%) and Sanofi S.A. (10%).
Directors
According to the 2025 annual accounts
Bart Vermeulen
Director
since 2024 · until 2027
since 2025 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Leonardo da Vincilaan 19
1831 Machelen (Brab.)
Wetenschapsstraat 14
1000 Brussel
Active since 1 January 2005
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 30 companies are registered at this address.
CHEVRON PHILLIPS CHEMICALS INTERNATIONAL
€ 1,523 million revenue · 2025
CGI Belgium
€ 24.4 million revenue · 2025
STRYKER
€ 61.1 million revenue · 2025
TARGUS
€ 206,352 gross margin · 2025
ARCADIUS
€ 32,203 gross margin · 2025
+25 more
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
Website info
Features
Security
Details
- Company number
- 0464.435.901
- VAT number
- BE 0464.435.901
- Registered office
- Leonardo da Vincilaan 19, 1831 Machelen (Brab.)
- Names & denominations
- SANOFI BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 October 1998
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- sanofi.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handelsbemiddeling gespecialiseerd in overige goederen, n.e.g.
Handelsbemiddeling in de groothandel in andere specifieke goederen